IFNG and cancer: Pathway analysis of progression vs. baseline biopsies from the converters demonstrated upregulation of several inflammatory pathways found previously to be activated in cancer stem cells42,43—interferon alpha, interferon gamma response, allograft rejection, IL6/JAK/STAT signaling, and TNF-alpha signaling via NFΚB.